SCHEMBL6277716

SCHEMBL6277716

CC(C)CCCC(N)CCC(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.48
BLM P54132 1/20 0.34
PLA2G1B P04054 1/20 0.33
PLA2G2A P14555 1/20 0.33
SLC1A3 P43003 1/20 0.32
SLC1A2 P43004 1/20 0.32
SLC1A1 P43005 1/20 0.32
OPRM1 P35372 1/20 0.32
ENPEP Q07075 1/20 0.32
ANPEP P15144 1/20 0.32
ERAP2 Q6P179 1/20 0.32
ERAP1 Q9NZ08 1/20 0.32
ALDH1A1 P00352 2/20 0.32
TSHR P16473 2/20 0.32
MAPK1 P28482 1/20 0.32
TRPV1 Q8NER1 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
NFKB1 P19838 1/20 0.31
THPO P40225 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7610543 0.87 TSHR (0.39) LMNASLC1A3SLC1A2SLC1A1OPRM1
SCHEMBL20978343 0.83 ALDH1A1 (0.47) LMNABLMPLA2G1BPLA2G2AOPRM1
SCHEMBL7429327 0.83 LMNA (0.43) LMNABLMPLA2G1BPLA2G2AALDH1A1
SCHEMBL24403199 0.83 OPRM1 (0.46) PLA2G1BPLA2G2AOPRM1ALDH1A1S1PR2
SCHEMBL7058526 0.83 OPRM1 (0.46) PLA2G1BPLA2G2AOPRM1ALDH1A1S1PR2
SCHEMBL6283626 0.81 OPRM1 (0.56) LMNABLMPLA2G1BPLA2G2AOPRM1
SCHEMBL22433303 0.81 SLC1A3 (0.33) LMNAPLA2G1BPLA2G2ASLC1A3SLC1A2
SCHEMBL4225215 0.80 LMNA (0.46) LMNABLMPLA2G1BPLA2G2AOPRM1
SCHEMBL18085360 0.80 LMNA (0.46) LMNABLMPLA2G1BPLA2G2AOPRM1
SCHEMBL16655069 0.80 LMNA (0.46) LMNABLMPLA2G1BPLA2G2AOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6919291-B2 Fluorinated zwitterionic cocatalyst activators for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2005-07-19 US disclosed
US-20040110631-A1 Fluorinated zwitterionic cocatalyst activators for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2004-06-10 US disclosed
EP-1349653-A2 FLUORINATED ZWITTERIONIC COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION ExxonMobil Chemical Patents Inc. (US) 2003-10-08 EP disclosed
WO-2002036639-A2 FLUORINATED ZWITTERIONIC COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2002-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110631-A1 Fluorinated zwitterionic cocatalyst activators for olefin polymerization FZD7, FOS, COG4 LMNA 2335/4885BLM 837/4885PLA2G1B 1285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.